The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program.

The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program. Inflamm Bowel Dis. 2025 Apr 10; 31(4):923-934.

View in: PubMed

subject areas

Adult
Aged
Biomarkers
Colitis, Ulcerative
C-Reactive Protein
Double-Blind Method
Feces
Female
Follow-Up Studies
Humans
Leukocyte L1 Antigen Complex
Male
Middle Aged
Prognosis
ROC Curve

authors with profiles

David Rubin